Influenza vaccine effectiveness and uptake in children at risk of severe disease

Pediatric Infectious Disease Journal

Volumn 35, Issue 3, 2016, Pages 309-315

  Blyth, Christopher C ^a,b,c   Jacoby, Peter ^c   Effler, Paul V ^d   Kelly, Heath ^e,f   Smith, David W ^a,g   Borland, Meredith L ^a,b   Willis, Gabriela A ^c   Levy, Avram ^a,f   Keil, Anthony D ^b   Richmond, Peter C ^a,b,c   Carcione, Dale ^h   Finucane, Cazz ^h   Geelhoed, Gary ^h   Leeb, Alan ^h   Lindsay, Katie ^h   Moore, Hannah ^h   Robins, Christine ^h   Tempone, Simone ^h   Van Buynder, Paul ^h   Williams, Simon ^h  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

^e VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^f AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^g PATHWEST LABORATORY MEDICINE   (Australia)

^h NONE

Author keywords

Children; Influenza; Trivalent influenza vaccine; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE; INACTIVATED VACCINE;

ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; EMERGENCY CARE; FEMALE; FLU LIKE SYNDROME; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PARENTAL ATTITUDE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER; RISK FACTOR; VACCINATION; CRITICAL ILLNESS; HISTORY; HOSPITAL EMERGENCY SERVICE; IMMUNOLOGY; INFANT; INFLUENZA, HUMAN; INTENSIVE CARE; OUTCOME ASSESSMENT; RISK; STATISTICS AND NUMERICAL DATA; WESTERN AUSTRALIA;

CHILD, PRESCHOOL; COMORBIDITY; CRITICAL CARE; CRITICAL ILLNESS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HISTORY, 21ST CENTURY; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RISK; RISK FACTORS; VACCINATION; VACCINES, INACTIVATED; WESTERN AUSTRALIA;

EID: 84959198620     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000999     Document Type: Article

References (32)

1. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-1340.
2. Fiore AE, Uyeki TM, Broder K, et al; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1-62.
3. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239.
4. O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004;113(3 pt 1):585-593.
5. Gill PJ, Ashdown HF, Wang K, et al. Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis. Lancet Respiratory Medicine. 2014;3:139-149.
6. Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061.
7. Australian Technical Advisory Group on Immunisation. Australian Immunisation Handbook. 10th ed. Canberra: Department of Health, Australian Government, National Health and Medical Research Council; 2013.
8. Blyth CC, Richmond PC, Jacoby P, et al. The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children. Vaccine. 2014;32:4075-4081.
9. Armstrong PK, Dowse GK, Effler PV, et al. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open. 2011;1:e000016.
10. Blyth CC, Currie AJ, Wiertsema SP, et al. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine. 2011;29:5107-5113.
11. Blyth CC, Jacoby P, Effler PV, et al; WAIVE Study Team. Effectiveness of trivalent flu vaccine in healthy young children. Pediatrics. 2014;133: e1218-e1225.
12. Chidlow G, Harnett G, Williams S, et al. Duplex real-time reverse transcriptase PCR assays for rapid detection and identification of pandemic (H1N1) 2009 and seasonal influenza A/H1, A/H3, and B viruses. J Clin Microbiol. 2010;48:862-866.
13. Chidlow GR, Harnett GB, Shellam GR, et al. An economical tandem multiplex real-time PCR technique for the detection of a comprehensive range of respiratory pathogens. Viruses. 2009;1:42-56.
14. Hyypiä T, Auvinen P, Maaronen M. Polymerase chain reaction for human picornaviruses. J Gen Virol. 1989;70 (pt 12):3261-3268.
15. Foppa IM, Haber M, Ferdinands JM, et al. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013;31:3104-3109.
16. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine. 2013;31:2165-2168.
17. Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36:623-631.
18. Cowling BJ, Chan KH, Feng S, et al. The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013. Vaccine. 2014;32:5278-5284.
19. Eisenberg KW, Szilagyi PG, Fairbrother G, et al; New Vaccine Surveillance Network. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics. 2008;122:911-919.
20. Hoberman A, Greenberg DP, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA. 2003;290:1608-1616.
21. Shuler CM, Iwamoto M, Bridges CB, et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics. 2007;119:e587-e595.
22. Blyth CC, Markus TY, Effler PV, et al. Ensuring safety of the 2011 trivalent influenza vaccine in young children. Med J Aust. 2011;195:52.
23. Wood NJ, Blyth CC, Willis GA, et al. The safety of seasonal influenza vaccines in Australian children in 2013. Med J Aust. 2014;201:596-600.
24. Daley MF, Crane LA, Chandramouli V, et al. Misperceptions about influenza vaccination among parents of healthy young children. Clin Pediatr (Phila). 2007;46:408-417.
25. Grant VJ, Le Saux N, Plint AC, et al. Factors influencing childhood influenza immunization. CMAJ. 2003;168:39-41.
26. Nowalk MP, Lin CJ, Zimmerman RK, et al. Changes in parents' perceptions of infant influenza vaccination over two years. J Natl Med Assoc. 2007;99:636-641.
27. Nowalk MP, Zimmerman RK, Lin CJ, et al. Parental perspectives on influenza immunization of children aged 6 to 23 months. Am J Prev Med. 2005;29:210-214.
28. Flint SM, Davis JS, Su JY, et al. Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia's Northern Territory. Med J Aust. 2010;192:617-622.
29. Harris PN, Dixit R, Francis F, et al. Pandemic influenza H1N1 2009 in north Queensland-risk factors for admission in a region with a large indigenous population. Commun Dis Intell Q Rep. 2010;34:102-109.
30. Trauer JM, Laurie KL, McDonnell J, et al. Differential effects of pandemic (H1N1) 2009 on remote and indigenous groups, Northern Territory, Australia, 2009. Emerg Infect Dis. 2011;17:1615-1623.
31. Grohskopf LA, Olsen SJ, Sokolow LZ, et al; Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep. 2014;63:691-697.
32. Public Health England, Department of Health and NHS England. Flu Plan: Winter 2015 to 2016. London: GOV.UK; 2015. Available at: https://www.gov. uk/government/publications/flu-plan-2015-to-2016. Accessed July 10, 2015.